Schwartz Aharon - Insider Non-Derivative Transactions at Protalix BioTherapeutics, Inc. (PLX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 3, 2023, Schwartz Aharon's relationship to Protalix BioTherapeutics, Inc. (PLX) is Director, and currently has 174,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PLX insiders.
Data Source: SEC.
Schwartz Aharon - Insider Non-Derivative Transactions at PLX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 4, 2023 | P -- (Common Stock) | 110000 | 1.42 | 174000 |